Sibionics

Company Deals

Sibionics Raises RMB 500 Million in Series D Financing Round

Fineline Cube Dec 21, 2022

Shenzhen-based chronic disease device maker Sibionics has reportedly raised close to RMB 500 million (USD...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod